Skip to main content

Advertisement

SpringerLink
Log in

Comment on: Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

References

  1. Zhang QL, Zhu LX, Zhou D et al (2023) Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis. Ann Hematol 102(9):2301–2308

    Article  PubMed  Google Scholar 

  2. Li N, Jiang M, Wu WC et al (2022) Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center. Hematology 27(1):909–916

    Article  PubMed  Google Scholar 

  3. Lei KI, Chan LY, Chan WY et al (2000) Quantitative analysis of circulating cell-free epstein-barr virus (EBV) DNA levels in patients with EBV -associated lymphoid malignancies. Br J Haematol 111(1):239–246

    CAS  PubMed  Google Scholar 

  4. Ramos-Casals M, Brito-Zerón P, López-Guillermo A et al (2014) Adult haemophagocytic syndrome. Lancet 383(9927):1503–1516

    Article  PubMed  Google Scholar 

  5. Castillo JJ, Beltran BE, Miranda RN et al (2018) EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management. Am J Hematol 93(7):953–962

    Article  CAS  PubMed  Google Scholar 

  6. Fei Q, Tian XK, Wu J et al (2018) Prognostic significance of Epstein–Barr virus DNA in NK/T-cell lymphoma: a meta-analysis. Onco Targets Ther 11:997–1004

    Article  PubMed  PubMed Central  Google Scholar 

  7. Zhang RX, Cui TT, He LB et al (2022) A study on early death prognosis model in adult patients with secondary hemophagocytic lymphohistiocytosis. J Healthc Eng 2022:6704859

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Oncology, West China School of Public Health and West China Fourth Hospital, Sichuan University, No.16 Section 3, Renmin South Road, Chengdu, 610044, China

    Na Li

  2. Department of Cardiothoracic Surgery, Chengdu Second People’s Hospital, Chengdu, 610017, China

    Han Cheng

Authors
  1. Na Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Han Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Na Li.

Ethics declarations

Ethics approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Consent to participate

Informed consent was exempted for this is a commence on other’s study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, N., Cheng, H. Comment on: Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis. Ann Hematol 103, 693–694 (2024). https://doi.org/10.1007/s00277-023-05504-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05504-y

Search

Navigation